Entries by drdeannaattai

,

Triple Negative Breast Cancer Disparities

14 July 2019 A study recently published in the journal Cancer* reports on disparities in triple negative breast cancer (TNBC). The researchers used the US cancer statistics database, and compared differences between TNBC and other breast cancer subtypes focusing on age, race / ethnicity, and stage at diagnosis.  Between 2010 and 2014, approximately 1.15 million […]

,

Tumor Heterogeneity and Prognosis

5 July 2019 We tend to think of most cancers as a single cell line, or clone – one normal cell develops a mutation, and that abnormal cell continues to divide. However, many tumors exhibit what is termed “heterogeneity” – meaning they are composed of cells with different genetic makeups. These cells can have different […]

,

Happy Birthday to #bcsm

1 July 2019 July 4th 2019 marks 8 years for the #bcsm (breast cancer social media) community on Twitter. #bcsm was started by two breast cancer patient advocates, Alicia Staley and Jody Schoger. They initially met on Twitter while participating in weekly tweet chats that focused on healthcare and social media (#hcsm). Sensing a need […]

,

Tips For New Docs

11 June 2019 July 1st is almost here, and a new class of surgical interns will soon be in place. It’s an exciting and at the same time unsettling period. Many who are well past the trainee phase have been sharing suggestions on making the successful transition from student to doctor via social media using […]

,

A New Option to Treat Metastatic Breast Cancer

4 June 2019 Encouraging news for patients with metastatic estrogen receptor-positive (ER+), Her2/neu negative breast cancer was presented at the 2019 American Society of Clinical Oncology annual meeting, and published in the New England Journal of Medicine. The MONALEESA-7 Phase III trial evaluated the use of ribociclib in combination with endocrine therapy. Patients who received […]

, , , , ,

Endocrine Therapy for Breast Cancer – Research Survey

13 May 2019 Note – the survey closed on July 7th 2019. Thank you to all who participated and shared, and we will be sure to post the results when they are available! Approximately 25-30% of patients with breast cancer who are prescribed endocrine therapy do not complete the full course of treatment, and some patients never […]